Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 2
2002 2
2003 2
2004 3
2005 1
2006 2
2007 1
2008 3
2009 2
2010 3
2011 1
2012 7
2013 6
2014 4
2015 5
2016 8
2017 6
2018 6
2019 8
2020 10
2021 9
2022 8
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.
Pulczynski EJ, Simonsen MR, Kuittinen O, Fagerli UM, Erlanson M, Fluge Ø, Leppä S, Østenstad B, Fosså A, Eriksson M, El-Galaly T, Kuitunen H, Papworth K, Ljungqvist M, Pedersen MB, Pollari M. Pulczynski EJ, et al. Among authors: kuittinen o. Haematologica. 2024 Mar 28. doi: 10.3324/haematol.2024.285207. Online ahead of print. Haematologica. 2024. PMID: 38546689 Free article.
Drug-induced pneumonitis risk in diffuse large B-cell/follicular lymphoma patients treated with R-CHOP-like regimen is associated with the use of granulocyte colony-stimulating growth factors.
Kaprio E, Prusila R, Tokola S, Kuusisto MEL, Jantunen E, Kuitunen H, Turpeenniemi-Hujanen T, Kuittinen O. Kaprio E, et al. Among authors: kuittinen o. Cancer Med. 2024 Jan 1;13(1):e6898. doi: 10.1002/cam4.6898. Online ahead of print. Cancer Med. 2024. PMID: 38164067 Free PMC article.
A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors.
Tiainen S, Nurmela V, Selander T, Turunen P, Pasonen-Seppänen S, Kettunen T, Kuittinen O, Auvinen P, Rönkä A. Tiainen S, et al. Among authors: kuittinen o. BMC Cancer. 2023 Dec 4;23(1):1186. doi: 10.1186/s12885-023-11699-0. BMC Cancer. 2023. PMID: 38049762 Free PMC article.
Real-world Data: MCL2 Protocol Demonstrates Excellent Treatment Results Among Patients With Mantle Cell Lymphoma Not Fulfilling the Original Trial Inclusion Criteria.
Harmanen M, Klaavuniemi T, Sorigue M, Khan M, Prusila R, Kari E, Alanne E, Rajamäki A, Sunela K, Jukkola A, Jantunen E, Sancho JM, Ketola S, Kuitunen H, Selander T, Rönkä A, Kuittinen O. Harmanen M, et al. Among authors: kuittinen o. Hemasphere. 2023 Sep 7;7(10):e954. doi: 10.1097/HS9.0000000000000954. eCollection 2023 Oct. Hemasphere. 2023. PMID: 37693119 Free PMC article. No abstract available.
Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation.
Partanen A, Turunen A, Valtola J, Pyörälä M, Kuittinen O, Kuitunen H, Vasala K, Penttilä K, Kuittinen T, Mäntymaa P, Pelkonen J, Jantunen E, Varmavuo V. Partanen A, et al. Among authors: kuittinen o. Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):e428-e435. doi: 10.1016/j.clml.2023.08.009. Epub 2023 Aug 18. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37684185 Free article.
100 results